The news began to filter out after the opening bell, and IsoRay’s stock opened at the about same price it closed at on Tuesday. However, volume began to pick up after 10 am EST and continued gaining ...
Micro-cap developer of novel brachytherapy technology IsoRay (ISR) shot up over 30 percent on Wednesday following publication of a peer-reviewed study showing improved results in treating ...
IsoRay (ISR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Isoray, Inc. (NYSE: ISR) and Viewpoint Molecular Targeting, Inc. is fair to Isoray ...
The market expects IsoRay (ISR) to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended December 2021. This widely-known consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results